Endothelin-targeted new treatments for proteinuric and inflammatory glomerular diseases: focus on the added value to anti-renin-angiotensin system inhibition
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Endothelin-targeted new treatments for proteinuric and inflammatory glomerular diseases: focus on the added value to anti-renin-angiotensin system inhibition
Authors
Keywords
-
Journal
PEDIATRIC NEPHROLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-03-17
DOI
10.1007/s00467-020-04518-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Single- and multiple-dose tolerability, safety, pharmacokinetics, and pharmacodynamics of the dual endothelin receptor antagonist aprocitentan in healthy adult and elderly subjects
- (2019) Patricia Sidharta et al. Drug Design Development and Therapy
- Endothelin receptor-A mediates degradation of the glomerular endothelial surface layer via pathologic crosstalk between activated podocytes and glomerular endothelial cells
- (2019) Kerstin Ebefors et al. KIDNEY INTERNATIONAL
- Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial
- (2019) Hiddo J L Heerspink et al. LANCET
- Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
- (2019) Vlado Perkovic et al. NEW ENGLAND JOURNAL OF MEDICINE
- Protecting Podocytes: A Key Target for Therapy of Focal Segmental Glomerulosclerosis
- (2018) Kirk N. Campbell et al. AMERICAN JOURNAL OF NEPHROLOGY
- Combined hydroxyurea and ETA receptor blockade reduces renal injury in the humanized sickle cell mouse
- (2018) Crystal Taylor et al. Acta Physiologica
- DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS
- (2018) Howard Trachtman et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Long-Term Endothelin-A Receptor Antagonism Provides Robust Renal Protection in Humanized Sickle Cell Disease Mice
- (2017) Malgorzata Kasztan et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Endothelin-1 Overexpression Exaggerates Diabetes-Induced Endothelial Dysfunction by Altering Oxidative Stress
- (2016) Noureddine Idris-Khodja et al. AMERICAN JOURNAL OF HYPERTENSION
- Steps on the Alport path to proteinuria
- (2016) Dale R. Abrahamson KIDNEY INTERNATIONAL
- Endothelin A receptor activation on mesangial cells initiates Alport glomerular disease
- (2016) Brianna Dufek et al. KIDNEY INTERNATIONAL
- Predictors of Atrasentan-Associated Fluid Retention and Change in Albuminuria in Patients with Diabetic Nephropathy
- (2015) D. E. Kohan et al. Clinical Journal of the American Society of Nephrology
- Sickle cell disease: renal manifestations and mechanisms
- (2015) Karl A. Nath et al. Nature Reviews Nephrology
- Key pathways in renal disease progression of experimental diabetes: Figure 1:
- (2015) Carlamaria Zoja et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Predictors of Congestive Heart Failure after Treatment with an Endothelin Receptor Antagonist
- (2014) J. Hoekman et al. Clinical Journal of the American Society of Nephrology
- Endothelial mitochondrial oxidative stress determines podocyte depletion in segmental glomerulosclerosis
- (2014) Ilse Daehn et al. JOURNAL OF CLINICAL INVESTIGATION
- Alport syndrome: its effects on the glomerular filtration barrier and implications for future treatment
- (2014) Judy Savige JOURNAL OF PHYSIOLOGY-LONDON
- Direct Action of Endothelin-1 on Podocytes Promotes Diabetic Glomerulosclerosis
- (2014) O. Lenoir et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The Endothelin Antagonist Atrasentan Lowers Residual Albuminuria in Patients with Type 2 Diabetic Nephropathy
- (2014) D. de Zeeuw et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Endothelin and endothelin antagonists in chronic kidney disease
- (2014) Donald E Kohan et al. KIDNEY INTERNATIONAL
- Recent Progress in the Pathophysiology and Treatment of FSGS Recurrence
- (2013) P. Cravedi et al. AMERICAN JOURNAL OF TRANSPLANTATION
- -Arrestin-1 Drives Endothelin-1-Mediated Podocyte Activation and Sustains Renal Injury
- (2013) S. Buelli et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Addition of ETA receptor blockade increases renoprotection provided by renin–angiotensin system blockade in 5/6 nephrectomized Ren-2 transgenic rats
- (2013) Věra Čertíková Chábová et al. LIFE SCIENCES
- Addition of Atrasentan to Renin-Angiotensin System Blockade Reduces Albuminuria in Diabetic Nephropathy
- (2011) D. E. Kohan et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Regulation of Blood Pressure and Salt Homeostasis by Endothelin
- (2011) Donald E. Kohan et al. PHYSIOLOGICAL REVIEWS
- Therapeutic potential of endothelin receptor antagonists for chronic proteinuric renal disease in humans
- (2010) Matthias Barton BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Angiotensin II revisited: new roles in inflammation, immunology and aging
- (2010) Ariela Benigni et al. EMBO Molecular Medicine
- Endothelin-1 Increases Glomerular Permeability and Inflammation Independent of Blood Pressure in the Rat
- (2010) Mohamed A. Saleh et al. HYPERTENSION
- Divergent Results Using Clinic and Ambulatory Blood Pressures
- (2010) George L. Bakris et al. HYPERTENSION
- Avosentan for Overt Diabetic Nephropathy
- (2010) J. F.E. Mann et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Dose-Dependent Acute and Sustained Renal Effects of the Endothelin Receptor Antagonist Avosentan in Healthy Subjects
- (2009) J Smolander et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The endothelin receptor antagonist avosentan ameliorates nephropathy and atherosclerosis in diabetic apolipoprotein E knockout mice
- (2009) A. M. D. Watson et al. DIABETOLOGIA
- Endothelin receptor selectivity in chronic renal failure
- (2009) L. Longaretti et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Endothelin receptor selectivity in chronic kidney disease: rationale and review of recent evidence
- (2009) W. Neuhofer et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Avosentan Reduces Albumin Excretion in Diabetics with Macroalbuminuria
- (2009) R. R. Wenzel et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Biology of endothelin receptors in the collecting duct
- (2009) Donald E. Kohan KIDNEY INTERNATIONAL
- Autosomal dominant polycystic kidney disease: the last 3 years
- (2009) Vicente E. Torres et al. KIDNEY INTERNATIONAL
- A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial
- (2009) Michael A Weber et al. LANCET
- Normalizing NADPH Oxidase Contributes to Attenuating Diabetic Nephropathy by the Dual Endothelin Receptor Antagonist CPU0213 in Rats
- (2008) Ming Xu et al. AMERICAN JOURNAL OF NEPHROLOGY
- Role of the renin–angiotensin–aldosterone system in collecting duct-derived endothelin-1 regulation of blood pressureThis article is one of a selection of papers published in the special issue (part 1 of 2) on Forefronts in Endothelin.
- (2008) Yuqiang Ge et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- Endothelin: 20 years from discovery to therapyThis article is one of a selection of papers published in the special issue (part 2 of 2) on Forefronts in Endothelin.
- (2008) Matthias Barton et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- Novel therapies of lupus nephritis
- (2008) Arrigo Schieppati et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Endothelin receptor antagonism prevents hypoxia-induced mortality and morbidity in a mouse model of sickle-cell disease
- (2008) Nathalie Sabaa et al. JOURNAL OF CLINICAL INVESTIGATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now